SLC6A8 and breast carcinoma: Notably, upregulation of SLC6A8 was found to be inversely related to the overall survival in cancer of lung, breast and skin, relapse free survival (RFS) in cancer of the lung and breast, and distant metastasis-free survival (DMFS) in breast cancer.